Two thirds of COVID-19 patients improve after Gilead drug – NEJM

More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc., according to new data based on patient observation. The analysis, published on Friday by the New England Journal of Medicine, does not detail […]